Boehringer Ingelheim has
confirmed the sale of its US-based
Roxane Laboratories specialty
generics operation to Hikma
Pharmaceuticals, in a deal worth
US$2.65 billion in cash and shares.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 29 Jul 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jul 15
PROFESSIONAL Pharmacists Australia (PPA) has lodged a whopping $160,000 underpayment claim on behalf of a Pharmacist-In-Charge member of the union, which described the case as “the worst example of wage theft we have seen”.